Aptose Biosciences Inc. Quarterly Common Stock, Value, Issued in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Aptose Biosciences Inc. quarterly Common Stock, Value, Issued history and growth rate from Q4 2017 to Q3 2024.
  • Aptose Biosciences Inc. Common Stock, Value, Issued for the quarter ending September 30, 2024 was $452M, a 1.88% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $452M +$8.36M +1.88% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $452M +$13.2M +3.01% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $450M +$12.5M +2.86% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $445M +$7.29M +1.67% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $444M +$6.47M +1.48% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $439M +$1.66M +0.38% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $438M +$534K +0.12% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $438M +$134K +0.03% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $437M +$7.67M +1.79% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $437M +$7.65M +1.78% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $437M +$7.76M +1.81% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $437M +$7.86M +1.83% Dec 31, 2021 10-K 2023-03-24
Q3 2021 $430M +$338K +0.08% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $430M +$63.5M +17.3% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $430M +$63.4M +17.3% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $430M +$64M +17.5% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $429M +$138M +47.4% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $366M +$75.1M +25.8% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $366M +$99M +37% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $365M +$104M +40% Dec 31, 2019 10-K 2021-03-23
Q3 2019 $291M +$36.6M +14.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $291M +$38.2M +15.1% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $267M +$26.5M +11% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $261M +$29.1M +12.6% Dec 31, 2018 10-K 2020-03-10
Q3 2018 $255M Sep 30, 2018 8-K 2019-03-12
Q2 2018 $253M Jun 30, 2018 8-K 2019-03-12
Q1 2018 $241M Mar 31, 2018 8-K 2019-03-12
Q4 2017 $232M Dec 31, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.